Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of the UK myeloma research alliance risk profile, a new clinical prediction model for outcome in patients with newly diagnosed multiple myeloma not eligible for autologous stem cell transplantation; a population-based study from the Danish national multiple myeloma registry.
Redder L, Klausen TW, Vangsted AJ, Gregersen H, Andersen NF, Pedersen RS, Szabo AG, Frederiksen M, Frølund UC, Helleberg C, Nielsen LK, Pedersen PT, Salomo M, Gimsing P, Frederiksen H, Abildgaard N. Redder L, et al. Among authors: szabo ag. Br J Haematol. 2021 Apr;193(1):119-124. doi: 10.1111/bjh.16806. Epub 2020 Jun 9. Br J Haematol. 2021. PMID: 32515050 Free article.
Prognostic indicators in primary plasma cell leukaemia: a multicentre retrospective study of 117 patients.
Jurczyszyn A, Radocha J, Davila J, Fiala MA, Gozzetti A, Grząśko N, Robak P, Hus I, Waszczuk-Gajda A, Guzicka-Kazimierczak R, Atilla E, Mele G, Sawicki W, Jayabalan DS, Charliński G, Szabo AG, Hajek R, Delforge M, Kopacz A, Fantl D, Waage A, Avivi I, Rodzaj M, Leleu X, Richez V, Knopińska-Posłuszny W, Masternak A, Yee AJ, Barchnicka A, Druzd-Sitek A, Guerrero-Garcia T, Liu J, Vesole DH, Castillo JJ. Jurczyszyn A, et al. Among authors: szabo ag. Br J Haematol. 2018 Mar;180(6):831-839. doi: 10.1111/bjh.15092. Epub 2018 Jan 7. Br J Haematol. 2018. PMID: 29315478 Free article. Clinical Trial.
Clinically-suspected cast nephropathy: A retrospective, national, real-world study.
Szabo AG, Thorsen J, Iversen KF, Hansen CT, Teodorescu EM, Pedersen SB, Flaeng SB, Strandholdt C, Frederiksen M, Vase MØ, Frølund UC, Krustrup D, Plesner T, Vangsted AJ. Szabo AG, et al. Am J Hematol. 2020 Nov;95(11):1352-1360. doi: 10.1002/ajh.25959. Epub 2020 Aug 26. Am J Hematol. 2020. PMID: 32777108 Free article.
Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio.
Szabo AG, Klausen TW, Abildgaard N, Gregersen H, Silkjær T, Pedersen PT, Pedersen RS, Helleberg C, Hermansen E, Schnack BI, Vangsted AJ. Szabo AG, et al. Blood Cancer J. 2021 Apr 7;11(4):70. doi: 10.1038/s41408-021-00460-0. Blood Cancer J. 2021. PMID: 33828079 Free PMC article. No abstract available.
Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients.
Højholt KL, Gregersen H, Szabo AG, Klausen TW, Levring MB, Preiss B, Helleberg C, Breinholt MF, Hermansen E, Rahbek Gjerdrum LM, Bønløkke ST, Nielsen K, Kjeldsen E, Iversen KF, Teodorescu EM, Kurt E, Strandholdt C, Andersen MK, Vangsted AJ. Højholt KL, et al. Among authors: szabo ag. Hematol Oncol. 2021 Oct;39(4):521-528. doi: 10.1002/hon.2906. Epub 2021 Aug 2. Hematol Oncol. 2021. PMID: 34342035
Outcome data from >10 000 multiple myeloma patients in the Danish and Swedish national registries.
Blimark CH, Vangsted AJ, Klausen TW, Gregersen H, Szabo AG, Hermansen E, Wålinder G, Knut-Bojanowska D, Zang C, Turesson I; Real-World Evidence Group within the Nordic Myeloma Study Group (NMSG). Blimark CH, et al. Among authors: szabo ag. Eur J Haematol. 2022 Feb;108(2):99-108. doi: 10.1111/ejh.13707. Epub 2021 Sep 23. Eur J Haematol. 2022. PMID: 34514635
The real-world outcomes of multiple myeloma patients treated with daratumumab.
Szabo AG, Klausen TW, Levring MB, Preiss B, Helleberg C, Breinholt MF, Hermansen E, Gjerdrum LMR, Bønløkke ST, Nielsen K, Kjeldsen E, Iversen KF, Teodorescu EM, Dokhi M, Kurt E, Strandholdt C, Andersen MK, Vangsted AJ. Szabo AG, et al. PLoS One. 2021 Oct 13;16(10):e0258487. doi: 10.1371/journal.pone.0258487. eCollection 2021. PLoS One. 2021. PMID: 34644367 Free PMC article.
The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy.
Szabo AG, Thorsen J, Iversen KF, Levring MB, Preiss B, Helleberg C, Breinholt MF, Hermansen E, Gjerdrum LMR, Bønløkke ST, Nielsen K, Kjeldsen E, Teodorescu EM, Dokhi M, Kurt E, Strandholdt CN, Andersen MK, Vangsted AJ. Szabo AG, et al. Am J Hematol. 2022 Mar 1;97(3):E117-E120. doi: 10.1002/ajh.26449. Epub 2021 Dec 29. Am J Hematol. 2022. PMID: 34967035 Free article. No abstract available.
96 results